Exploring the relationship between fever and cancer incidence

August 17, 2018, University of Chicago
A schematic illustration of the hypothesis presented in this article. Credit: Wieslaw Kozak, Tomasz Jedrzejewski, Malgorzata Pawlikowska, Jakub Piotrowski, and Sylwia Wrotek

Recurring patterns in patient accounts suggest the existence of an inverse relationship between personal history of infectious fever and cancer risk, and these patterns are documented throughout decades of medical literature. However, evidence supporting this correlation continues to be primarily anecdotal.

In "Toward Antitumor Immunity and Febrile Infections: Gamma/Delta (γδ) T Cells Hypothesis" published in The Quarterly Review of Biology, Wieslaw Kozak, Tomasz Jedrzejewski, Malgorzata Pawlikowska, Jakub Piotrowski, and Sylwia Wrotek propose a mechanistic hypothesis that focuses on the potential impact infectious fever has on a particular subset of T , known as gamma/delta (gd) T cells.

Drawing upon previous research and experimental data, the authors argue that repeated exposure to fever enhances the ability of gd T cells to detect cellular abnormalities and to foster inhospitable environments that destroy . This paper is the first to acknowledge the role that gd T cells may play as participants in this inverse relationship.

Infectious fever is the defensive and adaptive reaction that occurs when an organism's immune system comes into contact with exogenous pyrogens, or pathogen-associated molecular pattern (PAMP). Upon recognition of these exogenous pyrogens, endogenous mediators—also known as endogenous pyrogens—engage the febrile system. According to previous work by Shephard et al., a febrile system is composed of all of the mechanisms responsible for facilitating a fever as well as the various systems the fever affects. Thermoregulatory mechanisms are activated, resulting in the elevation of an organism's core body temperature.

The authors further elaborate on the function of endogenous mediators, like cytokines.

"In short, endogenous mediators of fever redirect metabolic substrates and energy to the immune system during fever. This markedly enhances the frequency of a vast range of immune effectors, including lymphocytes expressing gd heterodimer receptors, which possess a potent anti-infectious and antitumor competence," the authors write.

Gamma/delta T cells possesses receptors (TCRs) comprised of gamma/delta chain heterodimer. In fact, the authors posit that the unique attributes of gd T lymphocytes—lower TCR variability, fewer gene segment rearrangements, and TCRs with older evolutionary memory—enable the cells to enact processes that aid in decreasing , such as immune surveillance and attacking . Vg9Vd2 T cells are capable of responding to various types of cancer, such as carcinoma, lymphoma, prostate, myeloma, and sarcoma. Exposure to infection significantly expands the quantity of gd T cells. During infection, blood Vg9Vd2 T cells can increase in number until they constitute 60 percent of the total amount of lymphocytes.

While previous research and current cancer immunotherapy practices predominately focus on alpha/beta (ab) T cells, analysis of the interaction between and gd T cells may generate further inquiry into the larger impact and the clinical benefits of this relationship.

Explore further: A new role for an old immune cell may lead to novel therapies for infection and cancer

More information: Wieslaw Kozak et al, Toward Antitumor Immunity and Febrile Infections: Gamma/Delta (γδ) T Cells Hypothesis, The Quarterly Review of Biology (2018). DOI: 10.1086/699409

Related Stories

A new role for an old immune cell may lead to novel therapies for infection and cancer

March 1, 2017
A new study has identified a previously undescribed role for a type of unconventional T cell with the potential to be used in the development of new therapies for infection and cancer.

Research identifies unconventional immune cell capable of fighting viral infections

May 2, 2018
Research led by the University of Birmingham has identified a novel unconventional type of immune cell capable of fighting viral infections.

Natural lipid acts as potent anti-inflammatory

July 6, 2018
National Institutes of Health researchers have identified a naturally occurring lipid—a waxy, fatty acid—used by a disease-causing bacterium to impair the host immune response and increase the chance of infection. Inadvertently, ...

Two teams independently tease out gene expression patterns in tumor-infiltrating lymphocytes using RNA sequencing

June 27, 2018
Two teams working independently of each other have found that it is possible to tease out gene expression patterns in tumor-infiltrating lymphocytes using single-cell RNA sequencing. The first team, based in Australia, sequenced ...

Novel mechanism discovered in first line of immune defence

September 10, 2013
Scientists from A*STAR's Singapore Immunology Network (SIgN) have discovered a new defense mechanism that the immune system utilises to combat infections. The team's discovery of how a novel protein unexpectedly activates ...

Immune system infighting explains pancreatic cancer's aggression

August 25, 2016
Internal conflict between cell types explains why the immune system struggles to recognize and attack pancreatic cancer. Curbing this infighting has the potential to make treatment more effective, according to a study led ...

Recommended for you

Regulating the immune system's 'regulator'

November 20, 2018
A research team at the Academy of Immunology and Microbiology, within the Institute for Basic Science (IBS) has discovered a possible therapeutic target that pulls the reins of immunity. In Nature Communications, the scientists ...

New immunotherapy improves MS symptoms

November 20, 2018
A world-first clinical trial of a new cellular immunotherapy for multiple sclerosis (MS) has improved symptoms and quality of life for the majority of patients.

Scientists unveil completely human platform for testing age-specific vaccine responses

November 20, 2018
A team of scientists at Boston Children's Hospital has developed the first modeling system for testing age-specific human immune responses to vaccines—outside the body. The practical, cost-effective new platform, using ...

To resolve inflammation, location matters

November 19, 2018
Health conditions that involve inflammation run the gamut, from multiple sclerosis and lupus to arthritis, diabetes, and cancer. While inflammation can serve as a normal response to help the body deal with injury or infection, ...

New insights into how an ordinary stem cell becomes a powerful immune agent

November 19, 2018
How do individual developing cells choose and commit to their "identity"—to become, for example, an immune cell, or a muscle cell, or a neuron?

A gut bacterium as a fountain of youth? Well, let's start with reversing insulin resistance

November 16, 2018
Move over Bifidobacterium and Lactobacillus. There's a new health-promoting gut bacterium in town, and it's called Akkermansia muciniphila.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.